Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
28.71
+0.20 (0.70%)
Mar 4, 2026, 3:44 PM EST - Market open
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.27 billion as of March 4, 2026. Its market cap has increased by 345.23% in one year.
Market Cap
2.27B
Enterprise Value
1.67B
1-Year Change
345.23%
Ranking
Category
Stock Price
$28.71
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.27B, an increase of 263.59%. That is a compound annual growth rate of 52.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.26B | -21.44% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 2.53B |
| Adaptive Biotechnologies | 2.48B |
| Disc Medicine | 2.46B |
| Dyne Therapeutics | 2.41B |
| Dianthus Therapeutics | 2.40B |
| Immunome | 2.38B |
| Telix Pharmaceuticals | 2.35B |
| Ocular Therapeutix | 2.34B |